about
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...
Read More
14.47
-0.48
(-3.21%)
161.2K
XNAS Volume
XNAS 15 Jan, 2026 10:27 AM (EST)
Board Meeting
The latest board meeting for Regenxbio Inc took place on 14 Jan 2026, for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..